Indication data were not available
Hartman NR, Cysyk RL, Bruneau-Wack C, Thenot JP, Parker RJ, Strong JM
Patients are initiated on a gradual dosing schedule to optimize outcomes while minimizing potential side effects
For GLP-1 users specifically, the benchmarking approach is useful because it gives you concrete evidence of whether your strength is being preserved or declining during weight loss, something that is otherwise very difficult to track without baseline data
Post-Translational Modifications (PTMs): Many therapeutic peptides undergo PTMs (e.g., amidation, glycosylation) that impact their biological activity
disruptions in insulin signaling and chronic inflammation, hallmarks of obesity and dysmetabolism, greatly accelerate neurodegeneration